The Fleming Centre, which will be the headquarters of the Fleming Initiative, a joint partnership between Imperial College Healthcare NHS Trust and Imperial College London, will be the first in a planned global network of centres working to tackle the increasing, global threat of antimicrobial resistance (AMR).

Professor Tim Orchard, group chief executive of the North West London Acute Provider Group, which includes including Imperial College Healthcare, said: ‘This is a significant moment for the Fleming Centre and the fight against AMR, which will build on St Mary's Hospital's proud history of research, innovation and medical breakthroughs. It also supports our wider plans to redevelop the wider St Mary's site, bringing new opportunities and investment to the area as part of Paddington Life Sciences.'

The centre has been designed by Stanton Williams and is due to open in 2028, helping to mark the centenary of the discovery of penicillin at St Mary's Hospital by Sir Alexander Fleming.